Détail de l'auteur
Auteur M. HICKMAN |
Documents disponibles écrits par cet auteur (108)
Article : Périodique
J. M. KESTEN ; R. AYRES ; J. NEALE ; J. CLARK ; P. VICKERMAN ; M. HICKMAN ; S. REDWOOD |Background: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]NouveautéArticle : Périodique
R. MELOTTI ; J. HERON ; M. HICKMAN ; J. MACLEOD ; R. ARAYA ; G. LEWIS |Objective: To examine the association between use of alcohol and cigarettes among adolescents and their early socioeconomic background. Methods: Members of a longitudinal birth cohort (Avon Longitudinal Study of Parents and Children [ALSPAC], Un[...]Article : Périodique
A. I. STIBY ; M. HICKMAN ; M. R. MUNAFO ; J. HERON ; V. L. YIP ; J. MACLEOD |Aims: To investigate the relationship between cannabis and tobacco use by age 15 and subsequent educational outcomes. Design: Birth cohort study. Setting: England. Participants: The sample was drawn from the Avon Longitudinal Study of Parents[...]Article : Périodique
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT |BACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]Périodique
C. ACEIJAS ; E. OPPENHEIMER ; G. V. STIMSON ; R. E. ASHCRAFT ; S. MATIC ; M. HICKMAN | 2006Objective: To describe and estimate the availability of antiretroviral treatment (ART) to injecting drug users (IDUs) in developing and transitional countries. Methods: Literature review of grey and published literature and key informants' commu[...]Article : Périodique
C. ANGUS ; R. PRYCE ; J. HOLMES ; F. DE VOCHT ; M. HICKMAN ; P. MEIER ; A. BRENNAN ; D. GILLESPIE |BACKGROUND AND AIMS: When measuring inequalities in health, public health and addiction research has tended to focus on differences in average life-span between socio-economic groups. This does not account for the extent to which age of death va[...]Périodique
O. MORGAN ; C. GRIFFITHS ; M. HICKMAN | 2007ENGLISH : BACKGROUND: The UK heroin market is the biggest in Europe and approximately 70% of heroin deaths are due to fatal poisoning. Methadone treatment for heroin addiction in the UK, the 'British system', is unique as it is largely provide[...]Article : Périodique
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY |BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]Article : Périodique
C. M. COMISKEY ; A. L. BRETTEVILLE-JENSEN ; H. BERGERON ; G. BUHRINGER ; P. DARGAN ; M. DAVOLI ; F. FAGGIANO ; G. FISCHER ; F. RODRIGUEZ DE FONSECA ; H. GARRETSEN ; M. HICKMAN ; D. J. KORF ; K. KRAJEWSKI ; L. PAOLI ; R. SPANAGEL |With the breadth of new psychoactive substances and international policy changes, an analysis of specific responses in all areas of drug supply and demand is beyond the resources of a single country. The Scientific Committee of the European Moni[...]Article : Périodique
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL |Background: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]Article : Périodique
Aims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]Périodique
V. D. HOPE ; M. HICKMAN ; K. TILLING | 2005ENGLISH : Aim : To estimate the prevalence of crack cocaine use in 12 London Boroughs (and London as a whole). Setting : Twelve London Boroughs, 2000-01. Methods : (1) Covariate capture-recapture techniques applied to three data sources of sub[...]Article : Périodique
BACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]Périodique
M. FRISCHER ; M. HICKMAN ; L. KRAUS ; F. MARIANI ; L. WIESSING | 2001ENGLISH : Aims. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and pro[...]Article : Périodique
N. GOULDING ; M. HICKMAN ; M. REID ; E. J. AMUNDSEN ; J. A. BAZ-LOMBA ; J. W. O'BRIEN ; B. J. TSCHARKE ; P. DE VOOGT ; E. EMKE ; W. KUIJPERS ; W. HALL ; H. E. JONES |AIMS: To compare long-term trends in wastewater data with other indicators of stimulant use in three locations and to test the reliability of estimates based on 1 week of sampling. DESIGN: Comparison of trends in quantities ('loads') of stimula[...]Article : Périodique
R. MCGOVERN ; L. CROWE ; M. ADDISON ; M. HICKMAN ; J. KIDGER ; E. MCCOLL ; D. NEWBURY-BIRCH ; E. KANER |Heavy alcohol use and associated needs are prevalent amongst arrestees. The custody suite offers an opportunity to identify and intervene with this population. However, it is unclear whether functions of care can be effectively delivered within [...]Périodique
M. HICKMAN ; M. GRIFFIN ; J. MOTT ; J. CORKERY ; P. MADDEN ; SONDHI A. ; G. STIMSON | 2004ENGLISH : Aims : We discuss the Addicts Index (AI) and examine whether the epidemiological trends of the AI can be continued by the regional drug misuse databases (DMDs, now known as National Drug Treatment Monitoring System (NDTMS). Methods :[...]Article : Périodique
Studies published by Zule and colleagues have suggested that use of low dead-space syringes (LDSS) instead of high dead-space syringes (HDSS) by injecting drug users (IDUs) could dramatically reduce HIV transmission. However, evidence is limited[...]Article : Périodique
S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT |There is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]Article : Périodique
E. HANCOCK ; Z. WARD ; R. AYRES ; J. NEALE ; D. HUSSEY ; J. M. KESTEN ; M. HICKMAN ; P. VICKERMAN |BACKGROUND AND AIMS: Traditional detachable syringes used by people who inject drugs (PWID) retain larger volumes of blood when the plunger is depressed than syringes with fixed needles-referred to as high (HDSS) and low dead space syringes (LDS[...]Périodique
M. FRISHER ; S. ANDERSON ; M. HICKMAN ; HEATLIE H. | 2002Despite qualitative accounts of the spread of drug misuse in the UK there has been little epidemiological analysis of drug diffusion in recent years. This study used the data from the 1993 and 1996 Scottish Crime Surveys to investigate whether t[...]Article : Périodique
J. MARSDEN ; G. STILLWELL ; H. JONES ; A. COOPER ; B. EASTWOOD ; M. FARRELL ; T. LOWDEN ; N. MADDALENA ; C. METCALFE ; J. SHAW ; M. HICKMAN |Background and Aims: People with opioid use disorder (OUD) in prison face an acute risk of death after release. We estimated whether prison-based opioid substitution treatment (OST) reduces this risk. Design Prospective observational cohort stud[...]Article : Périodique
A. M. BARGAGLI ; M. HICKMAN ; M. DAVOLI ; C. A. PERUCCI ; P. SCHIFANO ; M. BUSTER ; T. BRUGAL ; J. VICENTE |ENGLISH : Objective: To estimate the mortality rates from drug-related deaths and other causes among problem drug users and population attributable risk of death due to opiate use in eight study sites in Europe. Methods: Opiate users were recr[...]Périodique
SCHIER J. G. ; L. S. NELSON ; R. S. HOFFMAN ; P. CUMMINGS ; J. MACLEOD ; M. HICKMAN ; G. D. SMITH ; K. J. S. ANAND ; M. T. LYNSKEY ; D. J. STATHAM ; N. G. MARTIN ; A. C. HEATH ; K. K. BUCHOLZ ; P. A. F. MADDEN ; E. C. NELSON ; W. S. SLUTSKE | 2003FRANÇAIS : Lettres à l'éditeur à propos de l'étude de "Escalation of drug use in early-onset cannabis users vs co-twins controls" publié dans JAMA, 2003, 289, 427-433, remettant en cause les résultats de cette étude.Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Article : Périodique
Objectif de la revue : Les interventions psychosociales sont des interventions verbales ou pratiques, ou les deux, dispensées à des individus ou à des groupes. Les interventions examinées dans cette revue cherchent à aider les parents à modifie[...]Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017Livre
Z. SLOBODA ; E. M. ADLAF ; M. D. ANGLIN ; M. L. BRECHT ; J. D. COLLIVER ; K. P. CONWAY ; D. C. DES JARLAIS ; K. W. ELIFSON ; S. R. FRIEDMAN ; C. FRY ; M. D. GLANTZ ; P. GRIFFITHS ; H. HAGAN ; W. HALL ; M. HICKMAN ; Y. I. HSER ; R. L. HUBBARD ; N. J. KOZEL ; T. LOCKE ; D. LONGSHORE ; R. McKETIN ; M. D. NEWCOMB ; J. A. RESKO ; C. E. STERK ; C. TAYLOR ; C. WALKER ; T. A. WILLS | New York : Springer Inc. | 2005ENGLISH : As the drug abuse epidemic evolves, so do the tools needed to understand and treat it. Accordingly, Epidemiology of Drug Abuse takes the long view, cogently outlining what the book calls "the natural history of drug abuse" and redefi[...]Article : Périodique
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY |BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]Périodique
C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN | 2006ENGLISH : OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature r[...]Article : Périodique
D. DE ANGELIS ; M. HICKMAN ; S. YANG |The authors explored an age-specific back-calculation approach to estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use (IDU) in England for 1968-2000. The incidence of opiate use/IDU was estimated by combi[...]Article : Périodique
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT |Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]Article : Périodique
H. E. JONES ; R. J. HARRIS ; B. C. DOWNING ; M. PIERCE ; T. MILLAR ; A. E. ADES ; N. J. WELTON ; A. M. PRESANIS ; D. DE ANGELIS ; M. HICKMAN |BACKGROUND AND AIMS: Indirect estimation methods are required for estimating the size of populations where only a proportion of individuals are observed directly, such as problem drug users (PDUs). Capture-recapture and multiplier methods are wi[...]Périodique
M. HICKMAN ; S. COX ; HARVEY J. ; S. HOWES ; M. FARRELL ; M. FRISCHER ; G. STIMSON ; C. TAYLOR ; K. TILLING | 1999FRANÇAIS : Objectifs : fournir une base sûre pour estimer la prévalence de l'usage de drogues dans le centre de Londres. Etude : revue de trois études portant sur un échantillon de sujets âgés de 15 à 49 ans, dans le but d'estimer la population[...]Article : Périodique
M. HICKMAN ; SEAMAN S. ; D. DE ANGELIS |In this paper, the authors propose a method for estimating the incidence of heroin use by adjusting reported numbers of heroin users visiting drug treatment agencies for the time lag between onset of heroin use and first treatment request (lag d[...]Périodique
M. HICKMAN ; C. TAYLOR ; A. CHATTERJEE ; L. DEGENHARDT ; M. FRISCHER ; G. HAY ; K. TILLING ; L. WIESSING ; P. GRIFFITHS ; R. McKETIN | 2002Les décideurs ont de plus en plus besoin d'estimations de la prévalence de la consommation problématique de drogues, comme l'usage par voie intraveineuse et la consommation de "crack". Dans cet article, les auteurs passent en revue les méthodes [...]Article : Périodique
S. SWEENEY ; Z. WARD ; L. PLATT ; L. GUINNESS ; M. HICKMAN ; V. HOPE ; L. MAHER ; J. IVERSEN ; S. J. HUTCHINSON ; J. SMITH ; R. AYRES ; I. HAINEY ; P. VICKERMAN |AIM: To evaluate the cost-effectiveness of needle and syringe programmes (NSPs) compared with no NSPs on hepatitis C virus (HCV) transmission in the United Kingdom. DESIGN: Cost-effectiveness analysis from a National Health Service (NHS)/healt[...]Article : Périodique
A. JUDD ; J. PARRY ; M. HICKMAN ; T. McDONALD ; L. JORDAN ; K. LEWIS ; CONTRERAS M. ; DUSHEIKO G. ; G. FOSTER ; N. GILL ; K. KEMP ; J. MAIN ; I. MURRAY-LYON ; M. NELSON |Oral fluid testing is an effective alternative to serum antibody testing for surveillance of human immunodeficiency virus (HIV) and hepatitis B infections, and is being extended to hepatitis C infections. The objective of this study was to deter[...]Article : Périodique
N. E. PALMATEER ; J. KIMBER ; M. HICKMAN ; S. HUTCHINSON ; T. RHODES ; D. GOLDBERG |AIMS: To review the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injec[...]Périodique
T. RHODES ; LOWNDES C. ; A. JUDD ; MIKHAILOVA L. A. ; SARANG A. ; RYLKOV A. ; TICHONOV M. ; K. LEWIS ; ULYANOVA N. ; T. ALPATOVA ; KARAVASHKIN V. ; KHUTORSKOY M. ; M. HICKMAN ; J. V. PARRY ; A. RENTON | 2002ENGLISH : Objective: To establish the prevalence of antibodies to HIV (anti-HIV) and associated risk factors among injecting drug users (IDU) in Togliatti City, Samara Oblast, Russian Federation. Design: An unlinked anonymous cross-sectional c[...]Article : Périodique
V. D. HOPE ; M. HICKMAN ; J. V. PARRY ; F. NCUBE |BACKGROUND: People who inject drugs (PWID) are at risk of injection site infections and injuries. The factors associated with recent symptoms of these problems are examined. METHOD: PWID recruited using respondent driven sampling, underwent a [...]Article : Périodique
V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE |BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]Article : Périodique
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT |BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]Article : Périodique
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT |BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Article : Périodique
J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY |BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]Périodique
C. ACEIJAS ; G. V. STIMSON ; M. HICKMAN ; T. RHODES | 2004ENGLISH : Objective: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries. Methods: Collation and review of existin[...]Article : Périodique
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY |We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]Article : Périodique
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY |Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT |Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]Article : Périodique
J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT |BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]Article : Périodique
A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT |AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]Rapport
OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]Périodique
A. JUDD ; M. HICKMAN ; A. RENTON ; G. STIMSON | 1999FRANÇAIS : Dans cet éditorial, les auteurs examinent diverses données épidémiologiques concernant les évolutions de prévalence des infections par les virus du sida et de l'hépatite C chez les usagers de drogues par voie intraveineuse et ce dan[...]Périodique
A. JUDD ; G. M. HUNTER ; MACONOCHIE N. ; M. HICKMAN ; J. V. PARRY ; RENTON A. M. ; G. V. STIMSON | 1999FRANÇAIS : Des enquêtes ont été menées auprès d'usagers de drogues, recrutés dans des structures de traitement ou de proximité du Grand Londres, en 1990 (173 personnes), 1991 (111 personnes), 1992 (128 personnes), 1993 (146 personnes) et en 199[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; H. ALI ; L. WIESSING ; M. HICKMAN ; R. P. MATTICK ; B. MYERS ; A. AMBEKAR ; S. A. STRATHDEE ; Reference Group to the UN on HIV and Injecting Drug Use |Background: Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate nat[...]Périodique
S. WILLIAMS ; M. HICKMAN ; BOTTLE A. ; P. AYLIN | 2004FRANÇAIS : Quelques données chiffrées sur les admissions à lhôpital en Angleterre et au Pays de Galles sur de 1996 à 2003.Article : Périodique
In the United Kingdom, as in many places, cannabis use is considered substantially within a criminal justice rather than a public health paradigm with prevention policy embodied in the Misuse of Drugs Act. In 2002 the maximum custodial sentence [...]Périodique
J. MACLEOD ; R. OAKES ; OPPENKOWSKI T. ; H. STOKES-LAMPARD ; A. COPELLO ; I. CROME ; G. D. SMITH ; M. EGGER ; M. HICKMAN ; A. JUDD | 2004ENGLISH : Recreational use of illicit drugs (i.e. use not associated with a diagnosed drug problem) may cause psychological and social harm. A recent systematic review found that evidence for this was equivocal. Extensive evidence was only ava[...]Article : Périodique
Concentrations of metabolites of illicit drugs in sewage water can be measured with great accuracy and precision, thanks to the development of sensitive and robust analytical methods. Based on assumptions about factors including the excretion pr[...]Article : Périodique
Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN |Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]Article : Périodique
J. STRANG ; W. HALL ; M. HICKMAN ; S. M. BIRD |Objective. To evaluate the impact of introduction of supervision of methadone dosing on deaths related to overdose of methadone in Scotland and England between 1993 and 2008 while controlling for increased prescribing of methadone. Design. Anal[...]Périodique
A. JUDD ; M. HICKMAN ; S. JONES ; T. McDONALD ; J. V. PARRY ; G. V. STIMSON ; A. J. HALL | 2005In England, the low prevalence of HIV among injecting drug users during the 1990s was attributed in part to the introduction of harm reduction interventions in the late 1980s. Also, the prevalence of hepatitis C virus in the late 1990s was thoug[...]Article : Périodique
S. A. McDONALD ; A. McAULEY ; M. HICKMAN ; S. M. BIRD ; A. WEIR ; K. TEMPLETON ; R. GUNSON ; S. J. HUTCHINSON |Background: In Europe, North America, and Australia, mortality due to drug-related (DR) causes amongst people who inject drugs (PWID) is a major issue. Our objective was to characterise temporal trends in DR mortality rates in a large cohort of [...]Article : Périodique
M. HICKMAN ; HIGGINS V. ; V. HOPE ; M. A. BELLIS ; K. TILLING ; A. WALKER ; J. HENRY |Study objective: To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators. Design: Capture-recapture techniques with covariate effects. Setting: Liverpool, Brig[...]Article : Périodique
L. T. TRAN ; A. PEACOCK ; S. COLLEDGE ; S. MEMEDOVIC ; J. GREBELY ; J. LEUNG ; S. LARNEY ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; M. HICKMAN ; L. DEGENHARDT |Background: Injecting risk behaviour, such as receptive sharing of injecting equipment and/or re-using one's equipment, is associated with bloodborne virus transmission and infections in people who inject drugs (PWID). We aimed to estimate preva[...]Article : Périodique
E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY |Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]Article : Périodique
N. PALMATEER ; V. HAMILL ; A. BERGENSTROM ; H. BLOOMFIELD ; L. GORDON ; J. STONE ; H. FRASER ; T. SEYLER ; Y. DUAN ; R. TRAN ; K. TRAYNER ; C. BIGGAM ; S. SMITH ; P. VICKERMAN ; M. HICKMAN ; S. HUTCHINSON |Background: Hepatitis C virus (HCV) and HIV remain prevalent among people who inject drugs (PWID) and transmission is usually associated with injecting risk behaviour (IRB). We update a 2011 review of reviews (RoR) to assess the latest evidence [...]Article : Périodique
G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON |BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these infections among people who inject drugs (PWID) is critical to reduce ongoing transmission, morbid[...]Article : Périodique
A. TAYLOR ; A. MUNRO ; E. ALLEN ; K. DUNLEAVY ; S. CAMERON ; L. MILLER ; M. HICKMAN |AIMS. To estimate hepatitis C virus (HCV) incidence and HCV risk among Scottish prisoners. DESIGN. National sero-behavioural survey; dried blood spots were collected in order to identify recent HCV infections (i.e. HCV antibody-negative and HCV[...]Article : Périodique
S. LARNEY ; H. JONES ; T. RHODES ; M. HICKMAN |Epidemiology is a core discipline generating evidence to inform and drive drug policy. In this essay, we speculate on what the future of drug epidemiology might become. We highlight for attention two areas shaping the future of drug epidemiology[...]Article : Périodique
G. M. HUNTER ; G. V. STIMSON ; A. JUDD ; S. JONES ; M. HICKMAN |FRANÇAIS : Buts : mesurer le comportement à risque chez des usagers de drogue intraveineux (UDI) à l'aide du questionnaire sur les risques de l'injection (QRI). Méthodes : les données ont été analysées à partir de la première enquête multi-site[...]Périodique
L. PLATT ; M. WALL ; T. RHODES ; A. JUDD ; M. HICKMAN ; L. JOHNSTON ; A. RENTON ; N. BOBROVA ; SARANG A. | 2006ENGLISH : Evidence suggests rapid diffusion of injecting drug use and associated outbreaks of HIV among injecting drug users (IDUs) in the Russian Federation and Eastern Europe. There remains a need for research among non-treatment and communi[...]Article : Périodique
H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN |BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]Article : Périodique
J. STONE ; N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; E. ASPINALL ; A. TAYLOR ; A. MUNRO ; K. DUNLEAVY ; E. PETERS ; P. BRAMLEY ; P. C. HAYES ; D. J. GOLDBERG ; P. VICKERMAN |Background and Aims: People who inject drugs (PWID) experience high incarceration rates, and previous incarceration is associated with elevated hepatitis C virus (HCV) transmission risk. In Scotland, national survey data indicate lower HCV incid[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; C. BUCELLO ; J. LEMON ; L. WIESSING ; M. HICKMAN |FRANÇAIS : Objectif : Examiner systématiquement les études de cohortes de la mortalité chez les toxicomanes par injection, étudier les taux de mortalité et les causes de décès dans ce groupe, et identifier les variables, au niveau des participa[...]Article : Périodique
L. DEGENHARDT ; C. BUCELLO ; B. MATHERS ; C. BRIEGLEB ; H. ALI ; M. HICKMAN ; J. MCLAREN |AIMS: To review the literature on mortality among dependent or regular users of opioids across regions, according to specific causes, and related to a number of demographic and clinical variables. METHODS: Multiple search strategies included sea[...]Article : Périodique
M. HICKMAN ; D. DE ANGELIS ; H. JONES ; R. J. HARRIS ; N. WELTON ; A. E. ADES |The quality of the evidence on estimating drug-related harm is not yet as advanced as that for intervention effectiveness. Multiple parameter evidence synthesis offers a potential solution, in which 'all available evidence' is combined into a si[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
V. D. HOPE ; J. V. PARRY ; F. NCUBE ; M. HICKMAN |Background: The extent of intentional or accidental subcutaneous and intramuscular injections and the factors associated with these have rarely been studied among people who inject drugs, yet these may play an important role in the acquisition b[...]Article : Périodique
G. J. MACARTHUR ; S. MINOZZI ; N. MARTIN ; P. VICKERMAN ; S. DEREN ; J. BRUNEAU ; L. DEGENHARDT ; M. HICKMAN |Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data [...]Périodique
J. PARSONS ; M. HICKMAN ; P. J. TURNBULL ; T. McSWEENEY ; G. V. STIMSON ; A. JUDD ; K. ROBERTS | 2002FRANÇAIS : Le nombre de seringues distribuées en avril 1997 est estimé à 1 707 000 et celui de l'année à 27 millions, à partir de 2000 lieux d'échange dans le Royaume-Uni. Le nombre de seringues distribuées en Ecosse est 3 à 4 fois plus bas que[...]Article : Périodique
K. P. HAYHURST ; M. PIERCE ; M. HICKMAN ; T. SEDDON ; G. DUNN ; J. KEANE ; T. MILLAR |Background: Although evidence points to a strong link between illicit drug use and crime, robust evidence for temporal order in the relationship is scant. We carried out a systematic review to assess the evidence for pathways through opiate/crac[...]NouveautéArticle : Périodique
J. HERON ; J. MACLEOD ; M. R. MUNAFO ; R. MELOTTI ; G. LEWIS ; K. TILLING ; M. HICKMAN |AIMS: Teenagers in the UK report some of the highest rates of alcohol use in Europe. We identify patterns of alcohol use in early adolescence and relate these to hazardous and harmful alcohol use at age 16. METHODS: In a UK birth cohort, we an[...]Article : Périodique
M. TAYLOR ; S. M. COLLIN ; M. R. MUNAFO ; J. MACLEOD ; M. HICKMAN ; J. HERON |Background: Evidence on the role of cannabis as a gateway drug is inconsistent. We characterise patterns of cannabis use among UK teenagers aged 13-18 years, and assess their influence on problematic substance use at age 21 years. Methods: We u[...]Article : Périodique
Background and Aims: Peer-led interventions may offer a beneficial approach in preventing substance use, but their impact has not yet been quantified. We conducted a systematic review to investigate and quantify the effect of peer-led interventi[...]Article : Périodique
E. F. KANER ; F. R. BEYER ; C. GARNETT ; D. CRANE ; J. BROWN ; C. MUIRHEAD ; J. REDMORE ; A. O'DONNELL ; J. J. NEWHAM ; F. DE VOCHT ; M. HICKMAN ; H. BROWN ; G. MANIATOPOULOS ; S. MICHIE |Review question: We aimed to find out if personalised advice to reduce heavy drinking provided using a computer or mobile device is better than nothing or printed information. We also compared advice provided using a computer or mobile device to[...]Article : Périodique
F. R. BEYER ; R. P. W. KENNY ; E. JOHNSON ; D. M. CALDWELL ; C. GARNETT ; S. RICE ; J. SIMPSON ; C. ANGUS ; D. CRAIG ; M. HICKMAN ; S. MICHIE ; E. F. S. KANER |AIM: To compare the effectiveness of practitioner versus digitally delivered interventions for reducing hazardous and harmful alcohol consumption. DESIGN: Systematic review and network meta-analysis comprising comprehensive search for randomise[...]Article : Périodique
V. D. HOPE ; A. JUDD ; M. HICKMAN |OBJECTIVES: This study sought to establish the prevalence of hepatitis C antibodies (anti-HCV) and hepatitis B antibodies (anti-HBc) among injection drug users in England and Wales. METHODS: A voluntary cross-sectional survey collected oral flu[...]Périodique
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study
T. RHODES ; L. PLATT ; S. MAXIMOVA ; E. KOSHKINA ; N. LATISHEVSKAYA ; M. HICKMAN ; A. RENTON ; N. BOBROVA ; T. McDONALD ; J. V. PARRY | 2006Objectives: To estimate the prevalence of HIV, hepatitis C virus (HCV) and syphilis in injecting drug users (IDUs) in Russia. Methods: Unlinked anonymous cross-sectional survey of 1473 IDUs recruited from non-treatment settings in Moscow, Volgog[...]Périodique
A. JUDD ; G. V. STIMSON ; M. HICKMAN ; G. M. HUNTER ; S. JONES ; J. V. PARRY ; P. MADDEN | 2000FRANÇAIS : 753 usagers de drogues injectables (UDVIs), recrutés dans 7 centres d'accueil anglais en 1997 et 1998, ont répondu à un questionnaire et ont fait l'objet d'un dépistage anonyme du VIH. La majorité était des hommes (71,1%) et près d'u[...]Article : Périodique
L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN |HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]Article : Périodique
H. E. JONES ; N. J. WELTON ; A. E. ADES ; M. PIERCE ; W. DAVIES ; B. COLEMAN ; T. MILLAR ; M. HICKMAN |Background and Aims: Capture-recapture (CRC) analysis is recommended for estimating the prevalence of problem drug use or people who inject drugs (PWID). We aim to demonstrate how naive application of CRC can lead to highly misleading results, a[...]Article : Périodique
J. MACLEOD ; R. OAKES ; A. COPELLO ; I. CROME ; M. EGGER ; M. HICKMAN ; OPPENKOWSKI T. ; H. STOKES-LAMPARD ; G. DAVEY SMITH |BACKGROUND: Use of illicit drugs, particularly cannabis, by young people is widespread and is associated with several types of psychological and social harm. These relations might not be causal. Causal relations would suggest that recreational d[...]Périodique
T. RHODES ; J. KIMBER ; W. SMALL ; J. FITZGERALD ; T. KERR ; M. HICKMAN ; G. HOLLOWAY | 2006Background: One key structural dimension in the distribution of drug-related harm associated with injecting drug use is the injecting environment. Epidemiological evidence associates elevated blood-borne viral risk with injecting in 'public' and[...]Article : Périodique
J. GREBELY ; G. ROBAEYS ; P. BRUGGMANN ; A. AGHEMO ; M. BACKMUND ; J. BRUNEAU ; J. BYRNE ; O. DALGARD ; J. J. FELD ; M. HELLARD ; M. HICKMAN ; A. KAUTZ ; A. LITWIN ; A. R. LLOYD ; S. MAUSS ; M. PRINS ; T. SWAN ; M. SCHAEFER ; L. E. TAYLOR ; G. J. DORE |Dans les pays à revenus élevés, la majorité des infections par le virus de l'hépatite C (VHC) nouvelles et existantes se produisent chez usagers de drogues par injection (UDI). Dans de nombreux pays à revenus faibles et moyens, de vastes épidémi[...]Article : Périodique
This article discusses approaches to assessing the size of the illicit market for powder cocaine, and the inherent difficulties of this issue. It describes recent attempts to investigate more accurate measures of the prevalence and extent of use[...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]NouveautéArticle : Périodique
H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN |Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]